Who is sponsoring NCT04399681?

NCT04399681 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

What condition does NCT04399681 study?

NCT04399681 studies COVID, Pneumonia, Viral.

What drugs are being tested in NCT04399681?

Interventions: Bedside lung ultrasound.

What is the status of NCT04399681?

NCT04399681 is currently UNKNOWN.

Last reviewed 2020-05-22 · How we verify

The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19

NCT04399681 NA UNKNOWN

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Details

Lead sponsor	Kanuni Sultan Suleyman Training and Research Hospital
Phase	NA
Status	UNKNOWN
Enrolment	100
Start date	Sun May 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Sep 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

COVID
Pneumonia, Viral

Interventions

Bedside lung ultrasound

Countries

Turkey (Türkiye)